HSICHenry Schein

$84.03+23% 1Y

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though earnings up +10% year on year.

1 good, 2 neutral
Revenue trend+6% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +3% a year.

Earnings trend+10% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+0.0 points operating

Trailing-twelve-month operating margin, 5.0% now against 5.0% a year earlier.

All from SEC EDGAR, as of Jun 27, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsmiddle of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is HSIC growing?

Henry Schein has grown revenue 2.6% a year over three years and 2.7% a year over five, with earnings per share compounding at 0.10%.

+2.6%

Revenue growth, 3-year annual rate · Healthcare median +11% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
+2.7%

Revenue growth, 5-year rate · +2.6% over three · growth has slowed since the five-year average

Earnings per share, 3-year rate
+0.10%

Earnings per share, 3-year rate · revenue +2.6% · earnings lagged revenue: the growth is costing something

Years of annual history on file
18

Years of annual history on file · FY2008 to FY2025, as filed

Details›
Revenue FY2021
$12.4B
Revenue FY2022
$12.6B
Revenue FY2023
$12.3B
Revenue FY2024
$12.7B
Revenue FY2025
$13.2B

Annual income statements as filed with the SEC.